Laura Hamilton to become CEO of North America for HealthBeacon
Nov 21ST 2019, Dublin, Ireland and Boston Headquartered, HealthBeacon, a leading global medical adherence technology provider whose mission is to “build smart tools for managing medications” will be establishing a dedicated North American division to drive the development of its business and technology platform across the USA and Canada.
It’s FDA cleared “best in class” medical adherence tool for tracking injectable medications has already been launched in 13 countries and has tracked over 300,000 Injections in patient’s homes, globally. At the recent Connected Health Conference in Boston, HealthBeacon published peer-reviewed evidence demonstrating the ability for patients to successfully adopt their technology as a result of patient-centered design. The platform has been designed to improve long term adherence to medication regimes and provide critical health data back to clinicians.
HealthBeacon’s Boston office can be described as just “Off Broadway” located above the CVS pharmacy on West Broadway in South Boston. Their Boston office has full business development, technical operations and customer care capabilities which are integrated into clinical systems, research organisations, and pharmaceutical patient support programs.
In her role as CEO of North America, Laura will be responsible for developing both the market and the HealthBeacon organisation across this important region and will report into Co-Founder and CEO, Jim Joyce.
“I first got to know Laura over 4 years ago in her time as Director of Business Development of the Massachusetts Biotechnology Council (MassBio) and in her capacity as President of BIBA (Boston Irish Business Association). She is a high energy, talented leader and we couldn’t be more excited to welcome her into the company at such an exciting time.” Jim Joyce, CEO and Co-Founder, HealthBeacon.
Upon joining the company this week, Laura stated, “I am delighted to be joining HealthBeacon as CEO of North America, based at the US Headquarters in Boston, MA. I’ve been closely connected to the company for many years and truly admire the leadership, the team they’ve developed, as well as the early successes they’ve achieved across Europe. The business is poised for tremendous growth in North America and is creating value in the healthcare ecosystem with their world leading technology, which tracks patient adherence to injectable medications for chronic disease. I’m so looking forward to getting started and joining the team of one of Ireland’s most innovative start-ups.”
MassBio President & CEO Robert Coughlin added, “The convergence between digital health and the life sciences is creating incredible opportunities to transform patient care. With Laura joining the team, I am excited to watch HealthBeacon grow in Massachusetts and beyond as it advances solutions to improve health outcomes.”
Laura most recently served as Executive Vice President, US Operations for RxCelerate, an outsourced drug discovery and drug development platform company based in Cambridge UK. Prior to that role, Laura was Director of Business Development at MassBio. She is a proud three-time graduate of Northeastern University in Boston with a BSBA in Finance, Masters Degree in Innovation (MSc) and Master of Business Administration (MBA). A native of Cork, Ireland, Laura is currently the President of the Boston Irish Business Association (BIBA) and also serves on the Board of Directors at the American Heart Association – Metro Boston.
Laura Hamilton HealthBeacon’s CEO of North America
HealthBeacon Boston Office